Skip to content
StockMarketAgent
§ How we look at healthcare

Standard 9-phase methodology applied with sector-appropriate emphasis on quality gates, valuation lens, and risk framing.

Top by upside
ABBV
+0.5%
AbbVie Inc.
hold· 2026-05-08
AMGN
+53.6%
Amgen Inc.
strong-buy· 2026-05-08
GILD
-1.2%
Gilead Sciences Inc.
hold· 2026-05-08